AX-024 HCl
CAS No. 1704801-24-0
AX-024 HCl ( —— )
Catalog No. M17365 CAS No. 1704801-24-0
AX-024 hydrochloride is an cytokine release inhibitor which can strongly inhibit the production of interleukin-6 (IL-6), tumor necrosis factor-α (TNFα), interferon-γ (IFN-γ), IL-10 and IL-17A.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 68 | In Stock |
|
5MG | 105 | In Stock |
|
10MG | 161 | In Stock |
|
25MG | 375 | In Stock |
|
50MG | 557 | In Stock |
|
100MG | 791 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAX-024 HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionAX-024 hydrochloride is an cytokine release inhibitor which can strongly inhibit the production of interleukin-6 (IL-6), tumor necrosis factor-α (TNFα), interferon-γ (IFN-γ), IL-10 and IL-17A.
-
DescriptionAX-024 hydrochloride is an cytokine release inhibitor which can strongly inhibit the production of interleukin-6 (IL-6), tumor necrosis factor-α (TNFα), interferon-γ (IFN-γ), IL-10 and IL-17A.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorIL-6; TNFα; IFN-γ; IL-10; IL-17A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1704801-24-0
-
Formula Weight375.87
-
Molecular FormulaC21H23ClFNO2
-
Purity98%
-
SolubilityDMSO : 33 mg/mL 87.80 mM; H2O : 16.67 mg/mL. 44.35 mM;
-
SMILESCl.Fc1ccc(cc1)C=3c4cc(ccc4OCC=3CN2CCCC2)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Borroto A, etal. First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases. Sci Transl Med. 2016 Dec 21;8(370):370ra184.
molnova catalog
related products
-
WAY-659694
WAY-659694 shows moderate acute anti-inflammatory activity and analgesic activity in vivo.
-
4-Methoxybenzoylacet...
The roots of Asarum sieboldii Miq.
-
(S,R,S)-AHPC-C10-NH2
(S,R,S)-AHPC-C10-NH2 is a synthesized E3 ligase ligand-linker conjugate incorporating the (S,R,S)-AHPC based VHL ligand and a linker used for BET-Targeted PROTAC.